Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome.
about
Hemophagocytic syndromes and infectionHemophagocytic Lymphohistiocytosis in Children: Pathogenesis and TreatmentInfectious MononucleosisHemophagocytic lymphohistiocytosis: an update on diagnosis and pathogenesisAcute Epstein-Barr virus infection presenting as severe gastroenteritis without infectious mononucleosis-like manifestations.Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives.Successful treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-94 protocolHuman herpesvirus-6 (HHV-6)-associated hemophagocytic syndrome.Treatment strategies for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH).Novel mouse xenograft models reveal a critical role of CD4+ T cells in the proliferation of EBV-infected T and NK cells.Outcome of clonal hemophagocytic lymphohistiocytosis: analysis of 32 cases.The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder.Humanized mouse models of epstein-barr virus infection and associated diseases.Hemophagocytic syndrome occurring in an adult liver transplant recipient having Still's disease.Modeling EBV infection and pathogenesis in new-generation humanized mice.Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferationsMassive expansion of EBV+ monoclonal T cells with CD5 down regulation in EBV-associated haemophagocytic lymphohistiocytosis.Characterization of Epstein-Barr virus (EBV)-infected cells in EBV-associated hemophagocytic lymphohistiocytosis in two patients with X-linked lymphoproliferative syndrome type 1 and type 2.Nasal angiocentric lymphoma with hemophagocytic syndrome.Infectious mononucleosis mimicking malignant T-cell lymphoma in the nasopharynx: a case report and review of the literature.Autoimmune-associated hemophagocytic syndrome.Fulminant EBV-driven CD8 T-cell lymphoproliferative disorder following primary acute EBV infection: a unique spectrum of T-cell malignancy.Systemic EBV+ T-cell lymphoma in elderly patients: comparison with children and young adult patients.Systemic Epstein-Barr virus-positive T-cell lymphoproliferative disease of childhood: Report of a case with review of the literatureTreatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens.Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome.Reproduction of epstein-barr virus infection and pathogenesis in humanized mice.Pediatric hemophagocytic syndromes: a diagnostic and therapeutic challengeHuman monocytic cell lines transformed in vitro by Epstein-Barr virus display a type II latency and LMP-1-dependent proliferation.Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group.Spectrum of childhood Epstein-Barr virus-associated T-cell proliferations and bone marrow findings.Fatal non-transplant-related epstein-barr virus-associated atypical lymphoid proliferations in infants and children: a clinicopathologic study.The use of cyclosporin-A in the treatment of virus-associated hemophagocytic syndrome in adults.An animal model for human EBV-associated hemophagocytic syndrome: herpesvirus papio frequently induces fatal lymphoproliferative disorders with hemophagocytic syndrome in rabbitsMolecular analysis of latent membrane protein 1 in patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.Use of serial assessment of disease severity and liver biopsy for indication for liver transplantation in pediatric Epstein-Barr virus-induced fulminant hepatic failure.Epstein-Barr virus: biology and disease.Latent Epstein-Barr virus infection in cottontop tamarins. A possible model for Epstein-Barr virus infection in humans.Epstein-Barr virus (EBV)-induced B-cell proliferative disorder after chemotherapy in a patient with hemophagocytic lymphohistiocytosis with associated EBV-induced T-cell proliferation.Killer cell immunoglobulin-like receptor gene polymorphisms predispose susceptibility to Epstein-Barr virus associated hemophagocytic lymphohistiocytosis in Chinese children.
P2860
Q24653852-766713E1-D4FD-4C99-8E96-993B4D35C8A2Q26744508-A6027F5D-1D7B-4EFA-B725-27357736AD3AQ26783692-CE4411D7-E8C1-43AA-ABA4-2893BBA45F7FQ27023603-DAF5D36A-9A74-4D85-A92F-98D8FD49CEABQ33424612-6C05B905-6DE6-435D-864F-3B59BCB0550AQ33503927-1367E249-BE45-42B6-B6C9-BE0DB3C2D8E0Q33599483-59F04B2B-0FA2-40FF-BF4E-9FBBDDC8C5C8Q33970258-6071600E-4D20-4F6E-B4B7-A9831C2E7696Q34024242-59A774D8-49A2-4BDE-BCA9-C45E0FEC5C3FQ34058148-43F14614-0886-4502-9905-99E179C4B7ABQ34066672-6EF90845-0B49-4C45-A932-1F1E4E921A17Q34371323-28E65135-E410-4945-B421-1DAE71CDA30AQ34533579-E56D1F26-24CC-4754-A4FC-A0953C2BA3D6Q34553515-0402B564-8988-4270-8BA1-50996B4A26EEQ35040650-0C24C0AC-BF16-48B4-AD44-64459119877CQ35232848-0C360D27-3082-4D8F-8892-5119B33E1941Q35770684-417AA840-1BD0-407E-B570-00B69ECE80F3Q35819248-4A29C2FE-B6B2-462F-BCCA-44B9B18C5969Q35938397-AF4ECD03-D43C-4687-956B-9D4F0E7F4058Q36449830-F651D721-54EB-49BF-947E-38CF173E729EQ36672859-FA04CB5C-2689-41CD-A01B-2C8004B03E3FQ36784912-C6031C92-7A20-4596-9278-A727D54EB959Q36837619-5EFBA75D-0230-4BD4-B43D-1E6175AF8225Q36905293-266F7B52-79D8-48C2-8C08-513F75768D24Q37180805-AD69BCD3-627A-4F00-8CA9-E1E594DCED24Q37373485-F8E5B4B1-68DB-43D0-9CFE-90CFC71E9652Q37617205-0E7A8793-DACF-4D7D-9BE2-5614D035C3E3Q37763298-77894D4A-C01F-44CD-96BD-BB09F521160DQ39683879-15846AFC-6DCA-4705-8ACB-8D1B3D25B95FQ40217608-5FC0E536-64FE-44FD-AD98-3D663925B7CDQ40362145-098A19BA-33E3-4419-A99B-40F291D18D7CQ40419375-2375C319-F9B2-483B-8375-E6F8FCF0CBF6Q40641188-4BD0F40D-5A9D-4265-A4D5-1A289CE65D43Q40814478-ABE004FA-CFE9-4A6A-933A-909220338E82Q40877030-7B3F9C2F-28A1-4EE3-9D51-55FD9AADD759Q41632476-153B8D63-6B4D-4BEE-B6C3-A7F6BF1096BFQ41697106-D3955007-A3BE-450D-BBC1-82CCBDA95DA8Q42754184-DF0614A4-AEDA-49B4-BBBC-EE0157D0A359Q44066503-99B606DC-9609-4F74-B0A9-6248677177BEQ44781881-62B8E687-4127-434B-B71B-919C1936AB6A
P2860
Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome.
description
1993 nî lūn-bûn
@nan
1993 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Epstein-Barr virus-infected T ...... iated hemophagocytic syndrome.
@ast
Epstein-Barr virus-infected T ...... iated hemophagocytic syndrome.
@en
type
label
Epstein-Barr virus-infected T ...... iated hemophagocytic syndrome.
@ast
Epstein-Barr virus-infected T ...... iated hemophagocytic syndrome.
@en
prefLabel
Epstein-Barr virus-infected T ...... iated hemophagocytic syndrome.
@ast
Epstein-Barr virus-infected T ...... iated hemophagocytic syndrome.
@en
P2093
P2860
P356
P1476
Epstein-Barr virus-infected T ...... iated hemophagocytic syndrome.
@en
P2093
Kawaguchi H
Kinoshita A
Kobayashi N
Miyashita T
Niedobitek G
Tsuchida M
P2860
P304
P356
10.1172/JCI116721
P407
P577
1993-09-01T00:00:00Z